Patent · US Active

Method for screening human ABO blood group-binding lactobacilli

US8465933B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2011
Grant dateJun 18, 2013
Priority date
Expiry dateSep 1, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/335
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Lactobacillus screening methods were carried out using surface plasmon resonance spectrums and human intestinal mucin and blood group antigens as probes. A trial to set selection criteria in the above-mentioned methods of screening for lactobacilli was made to adapt the methods to mass screening, and it was discovered that lactobacilli compatible with ABO blood groups can be screened by setting 100 RU as a criterion for judging bacterial binding under certain conditions. Using 238 lactobacillus strains, the above-mentioned screening methods and tests to judge their compatibility for the use of yogurt production were carried out, to at long last specifically discover bacillus strains compatible with blood groups A, B, and O.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.